Thursday, March 1, 2018

Karo Pharma Acquires a Major Product Portfolio

STOCKHOLM, March 1, 2018 /PRNewswire/ -- Karo Pharma acquires a product portfolio from the Danish pharmaceutical company LEO Pharma A/S for 260 MEURO, effective from 4th of April 2018. The turnover of the acquired product portfolio was ca 700 MSEK in 2017. Half of the...

from PR Newswire: //http://ift.tt/2oypjwg

No comments:

Post a Comment